103 studies found for:    Open Studies | "Conjunctivitis"
Show Display Options
Rank Status Study
1 Recruiting FST-100 in the Treatment of Acute Adenoviral Conjunctivitis
Condition: Acute Adenoviral Conjunctivitis
Interventions: Drug: FST-100;   Drug: FST-100 (Component #1);   Drug: FST-100 Vehicle
2 Recruiting Hydrocortisone Ophthalmic Ointment 0.5% for Treatment of Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Interventions: Drug: hydrocortisone ophthalmic ointment 0.5%;   Drug: placebo
3 Recruiting A Trial of Topical Dexamethasone Versus Artificial Tears for Treatment of Viral Conjunctivitis
Condition: Viral Conjunctivitis
Interventions: Drug: dexamethasone 0.1%/povidone-iodine 0.4%;   Drug: Artificial Tears
4 Unknown  Efficacy Maxinom® And Maxitrol® in Reducing The Signs And Symptoms Of Acute Bacterial Conjunctivitis
Conditions: Bacterial Conjunctivitis;   Acute
Interventions: Drug: MAXINOM®;   Drug: Maxitrol®
5 Recruiting ADenoVirus Initiative Study in Epidemiology in France
Condition: Viral Conjunctivitis
Intervention:
6 Recruiting ADenoVirus Initiative Study in Epidemiology in Germany
Condition: Viral Conjunctivitis
Intervention:
7 Not yet recruiting ADenoVirus Initiative Study in Epidemiology in UK
Condition: Viral Conjunctivitis
Intervention:
8 Unknown  Effectiveness Comparison Between the Drugs TOBRACORT® and TOBRADEX® in Reducing the Signs and Symptoms of Acute Bacterial Conjunctivitis
Condition: Acute Bacterial Conjunctivitis
Interventions: Drug: Tobracort;   Drug: Tobradex
9 Recruiting Safety and Efficacy Study of AL-53817 and AL-78843 Ophthalmic Solutions for Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Interventions: Drug: AL-53817 Ophthalmic Solution;   Drug: AL-78843 Ophthalmic Solution;   Drug: 0.1% Dexamethasone Ophthalmic Suspension;   Drug: AL-53817 Vehicle Ophthalmic Solution
10 Recruiting A Single Center Study for the Treatment of Moderate to Severe Allergic Conjunctivitis (EBI-005-AC-1)
Condition: Allergic Conjunctivitis
Interventions: Drug: Active Comparator EBI-005 5 mg/mL;   Drug: Placebo Comparator
11 Recruiting Efficacy/Safety of Human Plasminogen Eye Drop in Ligneous Conjunctivitis Patients
Condition: Ligneous Conjunctivitis
Intervention: Biological: Human Plasminogen
12 Not yet recruiting Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus
Conditions: Conjunctivitis;   Adenovirus.
Interventions: Drug: Ophthalmic gel (placebo);   Drug: Ganciclovir
13 Recruiting Efficacy and Safety of Auriclosene (NVC-422) in the Treatment of Bacterial Conjunctivitis
Condition: Bacterial Conjunctivitis
Interventions: Drug: Auriclosene Ophthalmic Solution;   Drug: Vehicle Ophthalmic Solution
14 Recruiting FST-100 in the Treatment of Acute Viral Conjunctivitis
Condition: Acute Viral Conjunctivitis
Interventions: Drug: FST-100;   Drug: FST-100 Vehicle
15 Not yet recruiting Phase 2/3 Study Evaluating Efficacy and Safety of OTX-DP for Treatment of Chronic Allergic Conjunctivitis
Condition: Allergic Conjunctivitis
Interventions: Drug: OTX-DP treatment;   Device: Placebo Plug with no drug
16 Unknown  Moxifloxacin vs. Polytrim for Conjunctivitis
Condition: Conjunctivitis
Interventions: Drug: moxifloxacin;   Drug: polytrim
17 Recruiting An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese Patients
Condition: Bacterial Conjunctivitis
Interventions: Drug: Moxifloxacin Ophthalmic Solution, 0.5%;   Drug: Ofloxacin Ophthalmic Solution, 0.3%
18 Recruiting AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis
Condition: Conjunctivitis, Allergic
Intervention: Drug: AGN-229666
19 Unknown  A Patient Reported Ocular Comfort Assessment Comparing Bepreve to Lastacaft
Condition: Allergic Conjunctivitis
Intervention:
20 Not yet recruiting Antibiotic Steroid Combination Compared With Individual Administration in the in the Treatment of Ocular Inflammation and Infection
Conditions: Ocular Inflammation;   Infection Associated Blepharitis;   Keratitis;   Conjunctivitis, Bacterial
Interventions: Drug: azithromycin 1.5%/Loteprednol 0,5% + placebo;   Drug: azithromycin 1.5% + Loteprednol 0,5% (separately)

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years